title: Serum homocyst(e)ine levels in women with preeclampsia.
abstract: BACKGROUND
  Endothelial dysfunction has been described as the final common pathophysiological pathway in the development of preeclampsia. Since it has been suggested that homocyst(e)ine damages endothelial cells, we measured serum homocyst(e)ine levels in women with preeclampsia and in healthy pregnant women in order to find a new prognostic parameter for women with preeclampsia.
  
  
  METHODS
  Forty-five women with preeclampsia and 45 healthy women with uncomplicated pregnancies, matched for age and parity, were entered into the study. Serum homocyst(e)ine levels were measured by gas chromatography-mass spectrometry analysis and correlated to clinical data. Logistic regression models were used to analyse the influence of serum homocyst(e)ine levels on the presence of preeclampsia versus healthy pregnant women and on the risk of premature termination of pregnancy due to preeclampsia.
  
  
  RESULTS
  Median serum homocyst(e)ine levels in women with preeclampsia and healthy pregnant women were 14.2 (range 5.7-38.1) mumol/L and 15.1 (range 5.2-23.1) mumol/L, respectively (Mann-Whitney U-test, p = 0.8). In univariate logistic regression models, serum homocyst(e)ine levels had no significant influence on the odds of presenting with preeclampsia versus healthy pregnant women (univariate logistic regression model, p = 0.8) and on the odds of premature termination of pregnancy due to preeclampsia (univariate logistic regression model, p = 0.3).
  
  
  CONCLUSIONS
  Serum homocyst(e)ine levels are not elevated in women with preeclampsia and are not associated with clinical outcome in women with preeclampsia.
authors.affiliation: Department of Gynecology and Obstetrics, University of Vienna Medical School, Austria. klaus.mayerhofer@akh-wien.ac.at
authors.forename: K
authors.initials: K
authors.lastname: Mayerhofer
authors.forename: L
authors.initials: L
authors.lastname: Hefler
authors.forename: H
authors.initials: H
authors.lastname: Zeisler
authors.forename: C
authors.initials: C
authors.lastname: Tempfer
authors.forename: K
authors.initials: K
authors.lastname: Bodner
authors.forename: S
authors.initials: S
authors.lastname: Stöckler-Ipsiroglu
authors.forename: A
authors.initials: A
authors.lastname: Mühl
authors.forename: A
authors.initials: A
authors.lastname: Kaider
authors.forename: C
authors.initials: C
authors.lastname: Schatten
authors.forename: S
authors.initials: S
authors.lastname: Leodolter
authors.forename: P
authors.initials: P
authors.lastname: Husslein
authors.forename: C
authors.initials: C
authors.lastname: Kainz
mesh_terms: D000328:Adult; D001724:Birth Weight; D003627:Data Interpretation, Statistical; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D016015:Logistic Models; D010298:Parity; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011379:Prognosis
chemical_list: D006710:Homocysteine